Join us at Discovery Europe and network with us and over 400 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, ASMS, target identification, validation and HIT optimization.
The 2-day program addresses emerging strategies for drug development within Neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases.
Click here for more information about the conference.
wednesday May 22nd
Track 3: 09:30-09:50 AM
Dr. Saman Honarnejad
“De-Risked Hit Finding And
Orthogonal Triaging Through
Mass Spectrometry”.
Pivot Park Screening Centre (PPSC) incorporated Affinity Selection Mass Spectrometry (ASMS) into its high-throughput screening operations, enhancing the study of protein-ligand interactions. This label-free, high-throughput compatible method allows for efficient screening of large compound libraries without the need for mobilization or extensive assay development.
Will you meet us there? Schedule your appointment with our experts here directly!
